• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Vaccinating boys plays key role in HPV prevention

, 26 August 2020/in E-News /by 3wmedia

Improving vaccination rates against the human papillomavirus (HPV) in boys aged 11 to 21 is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work.
HPV has been linked to anal, penile and certain types of throat cancers in men. Since the virus is also responsible for various cancers in women, vaccinating boys will play a crucial role in reducing cancer rates across the sexes.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:18Vaccinating boys plays key role in HPV prevention

Electronic tool helps reduce deaths from pneumonia in emergency departments

, 26 August 2020/in E-News /by 3wmedia

An electronic decision support tool helped to reduce deaths from pneumonia in four hospital emergency departments in a new study.
Although guidelines for treating pneumonia exist, it is often difficult for these to be fully implemented in an emergency setting. The researchers therefore developed an electronic tool, linked to a patient’s medical record. Unlike a paper guideline, the tool automatically extracts data that predict the severity of pneumonia. The tool then provides recommendations regarding where the patient should be admitted to, which diagnostic tests are best to use and which antibiotics are most appropriate.
Researchers from Intermountain Healthcare and the University of Utah in the USA tested the effectiveness of the tool on pneumonia patients in seven emergency departments. The first group of 2,308 patients were analysed before the electronic tool was used. A later group of 2,450 patients were assessed when four of the seven emergency departments used the electronic tool.
In both groups the researchers looked at hospital admission rates, length of hospital stay, deaths, secondary hospitalisation rates and adherence to guidelines.
The results showed a significant reduction in death rates in the emergency departments where the tool was used. Crude inpatient mortality rate fell from 5.3% to 3.5% and, after adjusting for severity, the relative risk of death was reduced by 25%. EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:25Electronic tool helps reduce deaths from pneumonia in emergency departments

New password in a heartbeat

, 26 August 2020/in E-News /by 3wmedia

Pacemakers, insulin pumps, defibrillators and other implantable medical devices often have wireless capabilities that allow emergency workers to monitor patients. But these devices have a potential downside: they can be hacked.
Researchers at Rice University have come up with a secure way to dramatically cut the risk that an implanted medical device (IMD) could be altered remotely without authorization.
Their technology would use the patient

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:06New password in a heartbeat

Potential new treatment for sepsis

, 26 August 2020/in E-News /by 3wmedia

Sepsis is the leading cause of in-hospital death and there is no specific treatment for it. Now, research led by Dr. Qingping Feng of Western University suggests a protein called recombinant human annexin A5 may have therapeutic potential for the treatment of this disease
Sepsis is caused by an overwhelming immune response to an existing infection. It

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:14Potential new treatment for sepsis

Early prone positioning reduces mortality of severe ARDS patients

, 26 August 2020/in E-News /by 3wmedia

Prone positioning has proved to be effective to improve oxygenation by promoting alveolar recruitment and to reduce ventilation- induced lung injury by homogenizing the distribution of stress and strain within the lungs.
Despite clear physiological benefits, most of the previous trials failed to prove that maintaining the acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) patient in prone position during mechanical ventilation provides a significant improvement in mortality compared to the standard semi-recumbent position.
However some of the post-hoc and meta-analysis showed that the most hypoxemic ARDS patients may benefit from this treatment.
In their recently published paper

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:21Early prone positioning reduces mortality of severe ARDS patients

Systems medicine paves the way for improved treatment for leukemia patients

, 26 August 2020/in E-News /by 3wmedia

A new individualised systems medicine strategy enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukaemia patients have been recently published
A multi-disciplinary team of researchers at the Institute for Molecular Medicine Finland, FIMM, and the Helsinki University Central Hospital has developed a novel individualised systems medicine (ISM) strategy which enables selection of potentially effective cancer therapies for individual patients.
Results achieved by applying this strategy to 28 patient samples have been recently published.
Most of the patients studied had chemoresistant adult acute myeloid leukaemia (AML), a disease characterised by poor prognosis.
AML is today largely treated by the same chemotherapeutic agents as applied 30-50 years ago. Here, the researchers measured the response of patients

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:09Systems medicine paves the way for improved treatment for leukemia patients

Low-frequency rTMS prevents chronic epileptic seizure

, 26 August 2020/in E-News /by 3wmedia

Although increasing evidence indicates that low-frequency repetitive transcranial magnetic stimulation (rTMS), an emerging technology for neural regulation, has antiepileptic effects, the mechanism remains unclear. Prof. Xiaoming Wang and team from the Affiliated Hospital of North Sichuan Medical College, China investigated the influence of low-frequency repetitive transcranial magnetic simulation on changes in several non-linear dynamic electroencephalographic parameters in rats with chronic epilepsy and explored the mechanism underlying repetitive transcranial magnetic simulation-induced antiepileptic effects. In their study, an epilepsy model was established using lithium-pilocarpine intraperitoneal injection into adult Sprague-Dawley rats, which were then treated with repetitive transcranial magnetic simulation for 7 consecutive days. Non-linear electroencephalographic parameters were obtained from the rats at 7, 14, and 28 days post-stimulation. Results showed significantly lower mean correlation-dimension and Kolmogorov-entropy values for stimulated rats than for non-stimulated rats. Low-frequency repetitive transcranial magnetic simulation has suppressive effects on electrical activity in epileptic rats, thus explaining its effectiveness in treating epilepsy. EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:16Low-frequency rTMS prevents chronic epileptic seizure

Proton therapy cuts side effects for pediatric head and neck cancer patients

, 26 August 2020/in E-News /by 3wmedia

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results were presented this week at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO) conference.
‘Children are especially susceptible to the side effects of radiation therapy, and treating them for head and neck cancers poses an additional challenge due to the risk of radiation to developing tissues,’ said the study

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:23Proton therapy cuts side effects for pediatric head and neck cancer patients

Oxygen decelerates many cancer tumours when combined with radiation therapy

, 26 August 2020/in E-News /by 3wmedia

A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumours can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumours in check with oxygen enhancement.
In research examining tissue oxygenation levels and predicting radiation response, UT Southwestern scientists led by Dr. Ralph Mason reported in the June 27 online issue of Magnetic Resonance in Medicine that countering hypoxic and aggressive tumours with an

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:11Oxygen decelerates many cancer tumours when combined with radiation therapy

Restoring surgeons? sense of touch during minimally invasive surgeries

, 26 August 2020/in E-News /by 3wmedia

A small, wireless capsule has been developed that can restore the sense of touch that surgeons are losing as they shift increasingly from open to minimally invasive surgery.

During open surgery, doctors rely on their sense of touch to identify the edges of hidden tumours and to locate hidden blood vessels and other anatomical structures: a procedure they call palpation. But this practice is not possible in minimally invasive surgery where surgeons work with small, specialized tools and miniature cameras that fit through small incisions in a patient

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:41:042020-08-26 14:41:18Restoring surgeons? sense of touch during minimally invasive surgeries
Page 104 of 235«‹102103104105106›»

Latest issue of International Hospital

April 2024

15 September 2025

Strategic menu swaps for hospital food could prompt patients to choose healthier options

12 September 2025

GPT-5 surpasses human doctors in medical diagnosis tests

12 September 2025

GE HealthCare launches premium AI-powered cardiovascular ultrasound

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription